Inverse expression of dihydrodiol dehydrogenase and glutathione-s- transferase in patients with esophageal squamous cell carcinoma

Liang Shun Wang, Kuan Chih Chow, Yu Chung Wu, Tze Yi Lin, Wing Yin Li

研究成果: 雜誌貢獻文章同行評審

38 引文 斯高帕斯(Scopus)

摘要

We investigated the significances of the expressions of dihydrodiol dehydrogenase (DDH) and glutathione-s-transferase (GST) in patients with esophageal squamous cell carcinoma (ESCC). By using immunohistochemistry, we measured expressions of DDH, GST, COX-2, nm23-HI, HER-2/ neu and mdr-I in 145 patients with ESCC. Expression of DDH was confirmed by immunoblotting and reverse transcription-polymerase chain reaction. Relation between DDH expression and clinicopathological parameters was analyzed by statistical analysis. Difference of survivals between different groups was compared by a log rank test. DDH overexpression was detected in 66.9% of pathological sections (97/ 145) and in 41.6% of metastatic lymph nodes (37/89). The nucleoticle sequencing of DNA fragments from 16 tumorous specimens showed that the major isoform was DDH2 for ESCC. GST expression, however, was only detected weakly in 24 patients (16.6%). For patients with ESCC, DDH overexpression was positively correlated with smoking habit, tumor stage, number of metastatic lymph nodes, lymphovascular invasion and COX-2 expression, and inversely correlated with GST and nm23-HI expressions, but not related to mdr-I or HER-2/neu expressions. As compared to DDH overexpressed group, patients with low DDH expression had significantly lower incidence of tumor recurrences and better survival (p = 0.026). Using univariate analysis, prognostic factors included tumor stage, number of metastatic lymph nodes, cell differentiation, lymphovascular invasion and expressions of DDH and nm23-HI. Multivariate analysis showed significant correlation of tumor stage, number of metastatic lymph nodes and nm23-HI expression with patient's survival. In conclusion, inverse expressions of DDH and GST may be associated with carcinogenesis and disease progression for ESCC patients, but their biological function and pathophysiological regulation in tumors require additional studies.

原文英語
頁(從 - 到)246-251
頁數6
期刊International Journal of Cancer
111
發行號2
DOIs
出版狀態已發佈 - 8月 20 2004
對外發佈

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Inverse expression of dihydrodiol dehydrogenase and glutathione-s- transferase in patients with esophageal squamous cell carcinoma」主題。共同形成了獨特的指紋。

引用此